高级搜索
鼻咽癌组织与外周血CD4+CD25+调节性T细胞检测及临床意义[J]. 肿瘤防治研究, 2009, 36(05): 400-404. DOI: 10.3971/j.issn.1000-8578.2009.05.011
引用本文: 鼻咽癌组织与外周血CD4+CD25+调节性T细胞检测及临床意义[J]. 肿瘤防治研究, 2009, 36(05): 400-404. DOI: 10.3971/j.issn.1000-8578.2009.05.011
Detection and Clinical Significance of CD4+CD25+ Regulatory T Cells in Patients with Nasopharyngeal Carcinoma[J]. Cancer Research on Prevention and Treatment, 2009, 36(05): 400-404. DOI: 10.3971/j.issn.1000-8578.2009.05.011
Citation: Detection and Clinical Significance of CD4+CD25+ Regulatory T Cells in Patients with Nasopharyngeal Carcinoma[J]. Cancer Research on Prevention and Treatment, 2009, 36(05): 400-404. DOI: 10.3971/j.issn.1000-8578.2009.05.011

鼻咽癌组织与外周血CD4+CD25+调节性T细胞检测及临床意义

Detection and Clinical Significance of CD4+CD25+ Regulatory T Cells in Patients with Nasopharyngeal Carcinoma

  • 摘要: 目的 通过检测鼻咽癌患者肿瘤组织及外周血中CD4+T、CD8+T、CD4+CD25-T、CD4+CD25+T细胞的频数,寻找客观、全面评价鼻咽癌患者免疫状态的临床指标。方法 采用流式细胞术检测40例初诊鼻咽癌患者及10例正常对照鼻咽部组织和外周血CD4+T、CD8+T、CD4+CD25-T、CD4+CD25+T细胞比例。结果 鼻咽癌患者CD4+T细胞比例及CD4+/ CD8+T比值均低于对照组(P<0.05),而CD8+T细胞两组间差异无统计学意义(P>0.05),但是CD4+/ CD8+T比值在鼻咽癌组织与外周血间差异无统计学意义(P>0.05)。鼻咽癌组织及外周血中CD4+CD25+T细胞比例都高于对照组(P<0.05),同时癌组织中该细胞比例远远高于外周血(P<0.05)。在鼻咽癌组织中CD4+CD25+T细胞与CD8+ T细胞、CD4+CD25-T细胞呈负相关(r分别为-0.70、-0.675,P<0.05),而在外周血中没有相关关系(P>0.05)。在不同T(原发肿瘤大小)组间,T4组的鼻咽癌组织中CD4+CD25+T细胞分别高于T1、T2、T3各组(P<0.05),而在T1、T2、T3各组间差异无统计学意义(P>0.05);鼻咽癌中CD4+CD25+T细胞比例与患者有无淋巴结转移并无关系(P>0.05);鼻咽癌组织中Ⅲ+Ⅳ期组CD4+CD25+T细胞比例高于Ⅰ+Ⅱ期组(P<0.05),而在外周血中两组间差异无统计学意义(P>0.05)。结论 CD4+CD25+T细胞与鼻咽癌病程进展无相关性,但是联合检测患者肿瘤组织及外周血中CD4+CD25+T细胞的频数并结合既往CD4+/ CD8+T比值会全面反应患者免疫状态,为临床治疗提供依据。

     

    Abstract: Objective To detect the frequency of CD4+T,CD8+ T,CD4+CD25-T,CD4+CD25+T cells in nasopharyngeal carcinoma (NPC), and to explore the objective clinical index to evaluate the immunity of NPC. Methods Flow Cytometry was to calculate the frequency of CD4+T,CD8+T,CD4+CD25-T,CD4+CD25+T cells in tumor tissue and peripheral blood from forty NPC and ten control. Results The proportion of CD4+T cells and ratio of CD4+/CD8+in NPC are significantly lower than those in control group(P<0.05),but there was no difference in CD8+T cells between two groups(P>0.05),there was also no significant difference in CD4+/CD8+between tumor tissue and peripheral blood in NPC(P>0.05). The ratios of CD4+CD25+T cells in tissue and peripheral blood of NPC was higher than control group, and the ratio in tumor tissue was dramatically higher than in peripheral blood in NPC(P<0.05).There was negative correlation between CD4+CD25+T cells and CD8+,CD4+CD25-T cells in tumor tissue of NPC respectively(r=-0.70,-0.675,P<0.05),but this was not seen in peripheral blood (P>0.05).According to the tumor sizes, patients with NPC were divided into four groups. The ratio of CD4+CD25+T cells in T4 tissue was higher than that in T1,T2,T3 respectively(P<0.05),but there was no difference among T1,T2,T3 groups(P>0.05).There was no correlation between frequency of CD4+CD25+T cells and lymphonode metastasis(P>0.05).The ratio of CD4+CD25+T cells in tumor tissue at stage Ⅲ+Ⅳ was higher than the stage Ⅰ+Ⅱ of NPC(P<0.05),but there was no difference between the two stage in peripheral blood in NP(P>0.05). Conclusion CD4+CD25+T cells was not correlated to the NPC prognosis, but detection of CD4+CD25+T cells in tissue and peripheral blood in NPC joint the ratio of CD4+/CD8+ which was used in the past will all-round evaluate the immunity of NPC, It may provide evidence for clinical therapy.

     

/

返回文章
返回